SAR 85.8
(0.94%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Revenue | 80.11 Million | 13.19 Million | 437.71 Thousand |
Cost of Revenue | 50.82 Million | 19.69 Million | 2.08 Million |
Gross Profit | 29.28 Million | -6.5 Million | -1.65 Million |
Operating Expenses | 18.46 Million | 18.41 Million | 9.16 Million |
Selling, General and Administrative Expenses | 20.24 Million | 18.23 Million | 9.1 Million |
Research and Development Expenses | - | - | - |
Other Expenses | -1.78 Million | -175.87 Thousand | -54.84 Thousand |
Cost and Expenses | 67.91 Million | 38.11 Million | 11.24 Million |
Operating Income | 12.19 Million | -24.91 Million | -10.81 Million |
Interest Expense | 13.58 Million | 4.26 Million | 5.31 Million |
Income Tax Expense | 40.45 Thousand | 1.00 | 33.2 Thousand |
Earnings before Tax | 802.68 Thousand | -25.24 Million | -11.12 Million |
Net Income | 762.22 Thousand | -25.24 Million | -11.15 Million |
Earnings Per Share Basic | 0.03 | -0.77 | -0.34 |
Earnings Per Share Diluted | 0.03 | -0.77 | -0.34 |
Weighted Average Shares Outstanding | 29.11 Million | 32.85 Million | 32.85 Million |
Weighted Average Shares Outstanding (Diluted) | 29.11 Million | 32.85 Million | 32.85 Million |
Gross Margin | 0.37 | -0.49 | -3.77 |
EBIT Margin | 0.41 | -1.01 | -22.74 |
Profit Margin | 0.01 | -1.91 | -25.48 |
EBITDA | 33.04 Million | -9.46 Million | -9.83 Million |
Earnings Before Tax Margin | 0.15 | -1.89 | -24.70 |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 73.64 Million | 80.11 Million | 54.03 Million | 27.01 Million | 26.07 Million | 13.03 Million |
Cost of Revenue | 39.95 Million | 50.82 Million | 29.16 Million | 14.58 Million | 20.29 Million | 10.14 Million |
Gross Profit | 33.68 Million | 29.28 Million | 24.87 Million | 12.43 Million | 5.77 Million | 2.88 Million |
Operating Expenses | 13.12 Million | 16.93 Million | 10.81 Million | 5.13 Million | 9.37 Million | 4.09 Million |
Selling, General and Administrative Expenses | 13.12 Million | - | 10.81 Million | 5.43 Million | 9.37 Million | 4.68 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | -302.73 Thousand | - | -297.1 Thousand | - | -597 Thousand |
Cost and Expenses | 53.08 Million | 67.76 Million | 39.97 Million | 19.71 Million | 29.67 Million | 14.23 Million |
Operating Income | 20.55 Million | 12.34 Million | 14.06 Million | 7.3 Million | -3.6 Million | -1.2 Million |
Interest Expense | 10.56 Million | 11.29 Million | 8.02 Million | - | 3.73 Million | - |
Income Tax Expense | 356.16 Thousand | 40.45 Thousand | 40.45 Thousand | 20.22 Thousand | 1.00 | - |
Earnings before Tax | 9.5 Million | 802.68 Thousand | 6.94 Million | 3.47 Million | -6.14 Million | -3.07 Million |
Net Income | 9.14 Million | 762.22 Thousand | 6.9 Million | 3.45 Million | -6.14 Million | -3.07 Million |
Earnings Per Share Basic | 0.28 | - | 0.21 | 0.12 | -0.19 | -0.11 |
Earnings Per Share Diluted | 0.28 | - | 0.21 | 0.12 | -0.19 | -0.11 |
Weighted Average Shares Outstanding | 32.85 Million | 29.11 Million | 32.85 Million | 29.47 Million | 32.85 Million | 28.75 Million |
Weighted Average Shares Outstanding (Diluted) | 32.85 Million | 29.11 Million | 32.85 Million | 29.47 Million | 32.85 Million | 28.75 Million |
Gross Margin | 0.46 | 0.37 | 0.46 | 0.46 | 0.22 | 0.22 |
EBIT Margin | 0.50 | - | 0.48 | 0.47 | 0.21 | 0.24 |
Profit Margin | 0.12 | 0.01 | 0.13 | 0.13 | -0.24 | -0.24 |
EBITDA | 36.87 Million | - | 25.9 Million | 12.82 Million | 5.5 Million | 3.07 Million |
Earnings Before Tax Margin | 0.28 | 0.15 | 0.26 | 0.27 | -0.14 | -0.09 |
NEXOF
UANG
TKAYF
ACE
MITT-PA
CHEMPLASTS